Published in Virology on October 01, 1993
Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system. J Virol (2001) 2.62
Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol (1994) 2.21
The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia. Proc Natl Acad Sci U S A (2006) 2.13
A preponderance of CCR5(+) CXCR4(+) mononuclear cells enhances gastrointestinal mucosal susceptibility to human immunodeficiency virus type 1 infection. J Virol (2001) 2.11
Transition between stochastic evolution and deterministic evolution in the presence of selection: general theory and application to virology. Microbiol Mol Biol Rev (2001) 2.06
Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J Virol (2005) 1.68
Evolutionary indicators of human immunodeficiency virus type 1 reservoirs and compartments. J Virol (2003) 1.62
In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop. J Virol (1994) 1.50
The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection. Microbiol Rev (1995) 1.34
Investigation of the dynamics of the spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17gag and env genes. J Virol (1997) 1.32
Determinants of syncytium formation in microglia by human immunodeficiency virus type 1: role of the V1/V2 domains. J Virol (2000) 1.14
Isolation and characterization of a neuropathogenic simian immunodeficiency virus derived from a sooty mangabey. J Virol (1998) 1.11
Conservation of an intact human immunodeficiency virus type 1 vif gene in vitro and in vivo. J Virol (1995) 1.06
Compartmentalization of surface envelope glycoprotein of human immunodeficiency virus type 1 during acute and chronic infection. J Virol (2002) 1.04
Reverse transcriptase sequence of paired isolates of cerebrospinal fluid and blood from patients infected with human immunodeficiency virus type 1 during zidovudine treatment. J Clin Microbiol (1995) 1.01
Small ruminant lentiviruses: genetic variability, tropism and diagnosis. Viruses (2013) 0.87
Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat. J Neurovirol (2012) 0.85
Correlation between CD4 T cell counts and virus compartmentalization in genital and systemic compartments of HIV-infected females. Virology (2011) 0.77
Contribution of adhesion to bacterial persistence in the mouse urinary tract. Infect Immun (1983) 14.71
Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group. Lancet (1998) 14.31
Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections. Infect Immun (1981) 5.24
Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect Immun (1983) 5.10
Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J Virol (1988) 4.96
Inhibition of experimental ascending urinary tract infection by an epithelial cell-surface receptor analogue. Nature (1982) 3.50
Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro. Proc Natl Acad Sci U S A (1992) 2.98
Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. Clin Infect Dis (1999) 2.75
Antibody response in primary human immunodeficiency virus infection. Lancet (1987) 2.69
Prognostic performance and customization of the SAPS II: results of a multicenter Austrian study. Simplified Acute Physiology Score. Intensive Care Med (1999) 2.61
Prospectively defined indicators to improve the safety and quality of care for critically ill patients: a report from the Task Force on Safety and Quality of the European Society of Intensive Care Medicine (ESICM). Intensive Care Med (2012) 2.49
The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group. N Engl J Med (1990) 2.46
Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local gram-negative infection. J Immunol (1987) 2.37
Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect Immun (1984) 2.35
Loss of memory (CD27) B lymphocytes in HIV-1 infection. AIDS (2001) 2.28
Adhesion of Escherichia coli in urinary tract infection. Ciba Found Symp (1981) 2.15
[Change in therapy target and therapy limitations in intensive care medicine. Position paper of the Ethics Section of the German Interdisciplinary Association for Intensive Care and Emergency Medicine]. Anaesthesist (2013) 2.14
Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults. J Neurol (2005) 2.04
Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. Liver (1999) 2.01
Infection of brain-derived cells with the human immunodeficiency virus. J Virol (1987) 2.01
Epidemiological aspects of Campylobacter jejuni enteritis. J Hyg (Lond) (1982) 1.95
A journey of hope: lessons learned from studies on rare diseases and orphan drugs. J Intern Med (2006) 1.90
The posttranscriptional control element of the simian retrovirus type 1 forms an extensive RNA secondary structure necessary for its function. J Virol (1996) 1.85
Campylobacter jejuni enteritis transmitted from cat to man. Lancet (1980) 1.85
Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: Two faces of Janus? Pharmacol Ther (2008) 1.85
Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J Infect Dis (1999) 1.84
CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology (2005) 1.73
Genotyping of hepatitis B virus by restriction pattern analysis of a pre-S amplicon. J Virol Methods (1998) 1.73
Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study. J Hepatol (1996) 1.73
High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha 2b for 60 weeks. Hepatology (1994) 1.71
A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB. AIDS Res Hum Retroviruses (1987) 1.67
Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol (1998) 1.64
Evaluation of the logistic organ dysfunction system for the assessment of organ dysfunction and mortality in critically ill patients. Intensive Care Med (2001) 1.61
Isolation of human immunodeficiency virus (HIV) from plasma during primary HIV infection. J Med Virol (1987) 1.61
Discrimination between antibodies to HIV and to related retroviruses using site-directed serology. Nature (1987) 1.59
Evaluation of an interdisciplinary data set for national intensive care unit assessment. Crit Care Med (1999) 1.56
Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection. J Acquir Immune Defic Syndr (1999) 1.53
Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. Am J Hum Genet (2001) 1.53
A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults. J Neurosci Methods (1994) 1.46
Sex-related differences in acetazolamide-induced cerebral vasomotor reactivity. Stroke (1996) 1.45
Bacterial virulence versus host resistance in the urinary tracts of mice. Infect Immun (1987) 1.45
Assessment of functional knee bracing: an in vivo three-dimensional kinematic analysis of the anterior cruciate deficient knee. Clin Biomech (Bristol, Avon) (2001) 1.44
Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J Viral Hepat (2000) 1.43
Bacterial adherence--a pathogenetic mechanism in urinary tract infections caused by Escherichia coli. Prog Allergy (1983) 1.42
HIV-1 RNA is not detectable in the cerebrospinal fluid during antiretroviral combination therapy. AIDS (1997) 1.39
Neuropathology of early HIV-1 infection. Brain Pathol (1996) 1.37
HIV antigenaemia and virus isolation from plasma during primary HIV infection. Lancet (1987) 1.33
Evidence for separate genetic defects in C3H/HeJ and C3HeB/FeJ mice, that affect susceptibility to gram-negative infections. J Immunol (1985) 1.32
Intraarticular lesions in distal fractures of the radius in young adults. A descriptive arthroscopic study in 50 patients. J Hand Surg Br (1997) 1.28
Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: epidemiological applications. J Med Virol (1994) 1.26
Genotoxicity of carbon nanofibers: are they potentially more or less dangerous than carbon nanotubes or asbestos? Toxicol Appl Pharmacol (2011) 1.25
Mother-to-infant transmission of hepatitis C virus. Ann Intern Med (1992) 1.23
Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection. J Viral Hepat (2002) 1.22
Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon. J Hepatol (1999) 1.21
Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection. Neurology (2007) 1.21
Cerebrospinal fluid neopterin concentrations in central nervous system infection. J Infect Dis (1993) 1.17
Apoptotic interactions of cytochrome c: redox flirting with anionic phospholipids within and outside of mitochondria. Biochim Biophys Acta (2006) 1.15
Immune activation and decreased tryptophan in patients with HIV-1 infection. J Interferon Res (1990) 1.15
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors lovastatin and simvastatin inhibit in vitro development of Plasmodium falciparum and Babesia divergens in human erythrocytes. Antimicrob Agents Chemother (1994) 1.14
Elevated serum levels of pancreatic secretory proteins in cigarette smokers after secretin stimulation. J Clin Invest (1980) 1.14
Idiopathic adhesive capsulitis of the shoulder: a review. Knee Surg Sports Traumatol Arthrosc (2007) 1.12
Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection--correlation with clinical progression, viral load, and loss of humoral immunity. Virology (1997) 1.12
Herpesvirus DNA detection in cerebral spinal fluid: differences in clinical presentation between alpha-, beta-, and gamma-herpesviruses. Scand J Infect Dis (2000) 1.12
Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment. Hepatology (1995) 1.11
Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection. Virology (1993) 1.11
IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1. J Viral Hepat (2011) 1.10
Acute viral encephalitis in adults--a prospective study. Scand J Infect Dis (1998) 1.10
The epidemiological pattern of hepatitis A, B, and non-A, non-B in Sweden. Scand J Gastroenterol (1978) 1.10
Antitoxin antibody levels and the outcome of illness during an outbreak of diphtheria among alcoholics. Scand J Infect Dis (1986) 1.09
Spectrum and clinical implications of syntaxin 11 gene mutations in familial haemophagocytic lymphohistiocytosis: association with disease-free remissions and haematopoietic malignancies. J Med Genet (2006) 1.09
Improved tissue culture technique for production of poorly replicating human immunodeficiency virus strains. J Virol Methods (1988) 1.09
Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors. Virology (1999) 1.09
Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity. Proc Natl Acad Sci U S A (1991) 1.08
Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1. AIDS (1989) 1.08
Mother to infant transmission of hepatitis C virus infection. J Med Virol (1990) 1.08
Central nervous system involvement in severe congenital neutropenia: neurological and neuropsychological abnormalities associated with specific HAX1 mutations. J Intern Med (2008) 1.08
Redox regulation of the caspases during apoptosis. Ann N Y Acad Sci (1998) 1.08
Increased accumulation of neutrophils and decreased fibrosis in the lung of NADPH oxidase-deficient C57BL/6 mice exposed to carbon nanotubes. Toxicol Appl Pharmacol (2008) 1.08
Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection. J Viral Hepat (2007) 1.07
Simultaneous detection of gastrointestinal pathogens with a multiplex Luminex-based molecular assay in stool samples from diarrhoeic patients. Clin Microbiol Infect (2013) 1.07
Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals. J Clin Microbiol (1992) 1.06
Anti-Fas IgG1 antibodies recognizing the same epitope of Fas/APO-1 mediate different biological effects in vitro. Int Immunol (1997) 1.06
N'Dribala (Cochlospermum planchonii) versus chloroquine for treatment of uncomplicated Plasmodium falciparum malaria. J Ethnopharmacol (2003) 1.06
Spectrum, and clinical and functional implications of UNC13D mutations in familial haemophagocytic lymphohistiocytosis. J Med Genet (2007) 1.06
Incidence and outcome of weaning from mechanical ventilation according to new categories. Eur Respir J (2009) 1.06
Hepatitis B virus carriers without precore mutations in hepatitis B e antigen-negative stage show more severe liver damage. Hepatology (1996) 1.05
Milk fat globule epidermal growth factor 8 (MFG-E8) binds to oxidized phosphatidylserine: implications for macrophage clearance of apoptotic cells. Cell Death Differ (2004) 1.05
Clinical, epidemiological and prognostic aspects of hepatitis A, B and "non-A, non-B". Scand J Infect Dis Suppl (1978) 1.05
HIV type 1 V3 sequences and the development of dementia during AIDS. AIDS Res Hum Retroviruses (1996) 1.05
Biological phenotype of HIV type 2 isolates correlates with V3 genotype. AIDS Res Hum Retroviruses (1996) 1.04
Progressive B cell apoptosis and expression of Fas ligand during human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses (1997) 1.04
Biological characterization of paired human immunodeficiency virus type 1 isolates from blood and cerebrospinal fluid. Virology (1989) 1.04